Atheroma and coronary bifurcations: Before and after stenting

EuroIntervention

Volumn 6, Issue SUPPL. J, 2010, Pages

  Yazdani, Saami K ^a   Nakano, Masataka ^a   Otsuka, Fumiyuki ^a   Kolodgie, Frank D ^a   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROMA; ATHEROSCLEROTIC PLAQUE; AUTOPSY; BARE METAL STENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY BIFURCATION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; NEOINTIMA; NONHUMAN; OUTCOME ASSESSMENT; REVIEW; SHEAR STRESS; STENT THROMBOSIS; WOUND HEALING;

EID: 79954458636     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/eijv6supja5     Document Type: Review

References (33)

1. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis (Dallas, Tex.) 1985;5:293-302.
2. Friedman MH, Bargeron CB, Deters OJ, Hutchins GM, Mark FF. Correlation between wall shear and intimal thickness at a coronary artery branch. Atherosclerosis. 1987;68:27-33. (Pubitemid 17151102)
3. Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol. 1998;18:677-85. (Pubitemid 28267645)
4. Sharma SK, Sweeny J, Kini AS. Coronary bifurcation lesions: a current update. Cardiol Clin. 2010;28:55-70.
5. Rizik DG, Klassen KJ, Hermiller JB. Bifurcation coronary artery disease: current techniques and future directions (part 1). J Invasive Cardiol. 2008;20:82-90. (Pubitemid 351271447)
6. Garot P, Lefevre T, Savage M, Louvard Y, Bamlet WR, Willerson JT, Morice MC, Holmes DR Jr. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol. 2005;46:606-12. (Pubitemid 41132685)
7. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR, Jr., Spanos V, Louvard Y, Desmedt B, Di Mario C, Leon MB. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109:1244-9. (Pubitemid 38372783)
8. Al Suwaidi J, Berger PB, Rihal CS, Garratt KN, Bell MR, Ting HH, Bresnahan JF, Grill DE, Holmes DR Jr. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol. 2000;35:929-36. (Pubitemid 30189924)
9. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-30. (Pubitemid 40617065)
10. Latib A, Colombo A. Bifurcation disease: what do we know, what should we do? JACC Cardiovasc Interv. 2008;1:218-26.
11. Prosi M, Perktold K, Ding Z, Friedman MH. Influence of curvature dynamics on pulsatile coronary artery flow in a realistic bifurcation model. J Biomech. 2004;37:1767-75. (Pubitemid 39237590)
12. He X, Ku DN. Pulsatile flow in the human left coronary artery bifurcation: average conditions. J Biomech Eng. 1996;118:74-82. (Pubitemid 26087285)
13. Fox B, James K, Morgan B, Seed A. Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis. 1982;41:337-47. (Pubitemid 12213364)
14. Grottum P, Svindland A, Walloe L. Localization of atherosclerotic lesions in the bifurcation of the main left coronary artery. Atherosclerosis. 1983;47:55-62. (Pubitemid 13117348)
15. Nakazawa G, Yazdani SK, Finn AV, Vorpahl M, Kolodgie FD, Virmani R. Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation. J Am Coll Cardiol. 2010 Apr 20;55:1679-87.
16. Cheng C, van Haperen R, de Waard M, van Damme LC, Tempel D, Hanemaaijer L, van Cappellen GW, Bos J, Slager CJ, Duncker DJ, van der Steen AF, de Crom R, Krams R. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood. 2005;106:3691-8. (Pubitemid 41739002)
17. Cheng C, Tempel D, van Haperen R, van der Baan A, Grosveld F, Daemen MJ, Krams R, de Crom R. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation. 2006;113:2744-53. (Pubitemid 43947992)
18. Perktold K, Peter RO, Resch M, Langs G. Pulsatile non-Newtonian blood flow in three-dimensional carotid bifurcation models: a numerical study of flow phenomena under different bifurcation angles. J Biomed Eng. 1991;13:507-15.
19. Richter Y, Groothuis A, Seifert P, Edelman ER. Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions. J clin invest. 2004;113:1607-14. (Pubitemid 39071684)
20. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23. (Pubitemid 37186209)
21. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-31. (Pubitemid 38067635)
22. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK, Kim JJ, Mintz GS, Park SW. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol. 2005;45:351-6. (Pubitemid 40186783)
23. Kim YH, Park SW, Lee SW, Park DW, Yun SC, Lee CW, Hong MK, Kim HS, Ko JK, Park JH, Lee JH, Choi SW, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Park SJ; Long-DES-II Study. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation. 2006;114:2148-53. (Pubitemid 44747895)
24. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370:937-48. (Pubitemid 47393576)
25. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667-78. (Pubitemid 46281313)
26. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus baremetal stents in Sweden. N Engl J Med. 2007;356:1009-19. (Pubitemid 46376801)
27. Farb A, Boam AB. Stent thrombosis redux - the FDA perspective. N Engl J Med. 2007;356:984-7. (Pubitemid 46376798)
28. Romagnoli E, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Ettori F, Franco G, Di Girolamo D, Sheiban I, Piatti L, Greco C, Petronio S, Loi B, Lioy E, Benassi A, Patti A, Gaspardone A, Capodanno D, Biondi- Zoccai GG, Sangiorgi G; I-BIGIS Study Group Milan, Italy. Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS). Am Heart J. 2010;160:535-42 e1.
29. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202. (Pubitemid 43929240)
30. Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation. 2005;111: 2958-65. (Pubitemid 40814189)
31. Koo BK, Park KW, Kang HJ, Cho YS, Chung WY, Youn TJ, Chae IH, Choi DJ, Tahk SJ, Oh BH, Park YB, Kim HS. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J. 2008;29:726-32.
32. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27:1500-10. (Pubitemid 46986103)
33. Sheiban I, Omede P, Biondi-Zoccai G, Moretti C, Sciuto F, Trevi GP. Update on dedicated bifurcation stents. J Interv Cardiol. 2009;22:150-5.